YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Pfizer Inc. plans to spend more on research and development, according to The Wall Street Journal.
Officials with the New York City-based drugmaker raised the company’s projections for R&D spending to a range of $7.7 billion to $8.1 billion. That’s up from a previous forecast of $7.4 billion to $7.9 billion.
The company expects 25 to 30 new drugs from its pipeline will be approved through 2022.
Read more from The Wall Street Journal.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Eric Schmitt introduces Modern Skies Act
Caterpillar to acquire John Fabick Tractor Co.
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach